CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients

Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis

Radiation Oncology Journal. 2022;40(2):151-161. Published online 2022 June 20 DOI: https://doi.org/10.3857/roj.2021.01032

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients

Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis

Radiation Oncology Journal. 2022;40(2):151-161

Link1

Link2 Link3

PO-0706: Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study

A. Magli, M.R. Malisan, E. Moretti, C. Foti, M. Crespi, M. Giangreco, A. Prisco, M. Poslinelli, G. Chiaulon, S. Fongione

Radiotherapy and Oncology. 2013;106:S271

Link1 Link2

168 oral Hypofractionated intensity modulated irradiation for prostate cancer: results from a phase I/II study

Radiotherapy and Oncology. 2004;73:S77

Link1 Link2

132 HYPOFRACTIONATED RADIOTHERAPY FOR LOW RISK PROSTATE CANCER: PRELIMINARY RESULTS OF A PHASE I/II TRIAL

C. Menkarios, D.H.A. Nguyen, É. Vigneault, N. Brochet, J.P. Bahary, M. Jolicoeur, T. Van Nguyen, M.C. Beauchemin, B. Fortin, M.A. Fortin, C. Lambert

Radiotherapy and Oncology. 2009;92:S42

Link1 Link2

53: Acute and Late Toxicity in High-Risk Prostate Cancer Patients Treated with Androgen Suppression and Hypofractionated Radiotherapy (Hyport) to the Prostate and Pelvic Nodes

Sergio Faria, Mariana Petrucelli, Fabio Cury, Marie Duclos, Luis Souhami

Radiotherapy and Oncology. 2016;120:S21

Link1 Link2

EP-1308: Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancer

A. Magli, T. Ceschia, E. Moretti, M. Signor, M. Polsinelli, A. Prisco, M. Crespi, C. Foti, M.R. Malisan, S. Fongione

Radiotherapy and Oncology. 2014;111:S91

Link1 Link2

PO-0717: Phase II study of hypofractionated stereotactic RT in recurrent HGG: preliminary results

G.A. Carta

Radiotherapy and Oncology. 2018;127:S367

Link1 Link2

Phase I/II Study of a Five-fraction Hypofractionated Accelerated Radiotherapy Treatment for Low-risk Localised Prostate Cancer: Early Results of pHART3

C.I. Tang, D.A. Loblaw, P. Cheung, L. Holden, G. Morton, P.S. Basran, R. Tirona, M. Cardoso, G. Pang, S. Gardner, A. Cesta

Clinical Oncology. 2008;20(10):729-737

Link1 Link2

Radiobiological Modeling and the Study of Hypofractionated Radiotherapy for Prostate Cancer

Mark K. Buyyounouski

European Urology. 2014;66(6):1031-1032

Link1 Link2

Preliminary Outcomes for Treatment of High Intermediate- and High-risk Prostate Cancer Patients using Pelvic Intensity Modulated Radiotherapy with Hypofractionated Simultaneous Integrated Boost to Prostate

K. Reddy, B.C. Nelson, R. McCammon, K.E. Rusthoven, F. Newman, B. Kavanagh, D. Raben

International Journal of Radiation Oncology*Biology*Physics. 2010;78(3):S376

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Radiat Oncol J has participated in CrossRef Text and Data Mining service since October 29, 2014.